Using radioimmunoassay techniques, Eng analyzed Gila monster venom and saliva
However, because GLP-1 slows gastric emptying, its essential to adjust your eating habits and choose foods that support digestion, prevent nausea, and keep you feeling balanced
Yoshinori Abe advises, "GLP-1 users should track body composition, waist size, strength, and metabolic labs rather than weight or BMI alone, since BMI cannot show fat versus muscle." Pay attention to your physical strength as well
Research Use Only Notice: Retatrutide is a research peptide intended for in-vitro and animal research applications only
Across the three pivotal trials, peak mean body-weight reductions rank retatrutide 12 mg at 24.2% (48 weeks, Phase 2), tirzepatide 15 mg at 22.5% (72 weeks, Phase 3), and semaglutide 2.4 mg at 14.9% (68 weeks, Phase 3) [1][2][5]
A responsible doctor or nurse practitioner will assess your medical history, health conditions, and individual needs to determine if GLP-1 medications are appropriate for you
